Kingwell E - Search Results

1

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.

Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H. Kingwell E, et al. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):61-6. doi: 10.1136/jnnp-2011-300616. Epub 2011 Aug 23. J Neurol Neurosurg Psychiatry. 2012. PMID: 21865212

2

Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?

Kingwell E, Tremlett H. Kingwell E, et al. Expert Rev Neurother. 2009 Sep;9(9):1263-5. doi: 10.1586/ern.09.76. Expert Rev Neurother. 2009. PMID: 19769440 No abstract available.

3

The natural history of primary progressive multiple sclerosis.

Koch M, Kingwell E, Rieckmann P, Tremlett H. Koch M, et al. Among authors: kingwell e. Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f. Neurology. 2009. PMID: 19996074

4

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.

Kingwell E, Leung AL, Roger E, Duquette P, Rieckmann P, Tremlett H; UBC MS Neurologists. Kingwell E, et al. J Neurol Sci. 2010 May 15;292(1-2):57-62. doi: 10.1016/j.jns.2010.02.007. Epub 2010 Mar 4. J Neurol Sci. 2010. PMID: 20202651

5

Disease onset in familial and sporadic primary progressive multiple sclerosis.

Koch M, Zhao Y, Yee I, Guimond C, Kingwell E, Rieckmann P, Sadovnick D, Tremlett H; UBC MS Clinic Neurologists. Koch M, et al. Among authors: kingwell e. Mult Scler. 2010 Jun;16(6):694-700. doi: 10.1177/1352458510367661. Epub 2010 Apr 8. Mult Scler. 2010. PMID: 20378663

6

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

Kingwell E, Koch M, Leung B, Isserow S, Geddes J, Rieckmann P, Tremlett H. Kingwell E, et al. Neurology. 2010 Jun 1;74(22):1822-6. doi: 10.1212/WNL.0b013e3181e0f7e6. Epub 2010 Apr 28. Neurology. 2010. PMID: 20427751 Free PMC article.

7

The natural history of secondary progressive multiple sclerosis.

Koch M, Kingwell E, Rieckmann P, Tremlett H; UBC MS Clinic Neurologists. Koch M, et al. Among authors: kingwell e. J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1039-43. doi: 10.1136/jnnp.2010.208173. Epub 2010 Jul 16. J Neurol Neurosurg Psychiatry. 2010. PMID: 20639385

8

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study.

Chan S, Kingwell E, Oger J, Yoshida E, Tremlett H. Chan S, et al. Among authors: kingwell e. Mult Scler. 2011 Mar;17(3):361-7. doi: 10.1177/1352458510388823. Epub 2010 Dec 10. Mult Scler. 2011. PMID: 21148660

9

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

Shirani A, Zhao Y, Kingwell E, Rieckmann P, Tremlett H. Shirani A, et al. Among authors: kingwell e. Mult Scler. 2012 Apr;18(4):442-50. doi: 10.1177/1352458511422097. Epub 2011 Sep 27. Mult Scler. 2012. PMID: 21952097

10

Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database study.

Evans C, Tam J, Kingwell E, Oger J; University of British Columbia MS Clinic Neurologists; Tremlett H. Evans C, et al. Among authors: kingwell e. Clin Ther. 2012 Feb;34(2):341-50. doi: 10.1016/j.clinthera.2012.01.006. Epub 2012 Jan 31. Clin Ther. 2012. PMID: 22296946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters